Should MMF treatment be the first-line therapy in autoimmune hepatitis?

J Hepatol. 2024 Feb 23:S0168-8278(24)00134-X. doi: 10.1016/j.jhep.2024.02.014. Online ahead of print.

Author

Laurent Alric¹

Affiliation

¹ Internal Medicine- Department of Gastroenterology and Hepatology, Rangueil Hospital, Toulouse 3 University, Toulouse, France. Electronic address: alric.l@chu-toulouse.fr.

PMID: 38403032
DOI: 10.1016/j.jhep.2024.02.014

No abstract available

Publication types

Letter